Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells

Joachim Bischof; Mike-Andrew Westhoff; Johanna Elisabeth Wagner; Marc-Eric Halatsch; Stephanie Trentmann; Uwe Knippschild; Christian Rainer Wirtz; Timo Burster

doi:10.1177/1010428317692227

Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells

Joachim Bischof, Mike-Andrew Westhoff, Johanna Elisabeth Wagner, Marc-Eric Halatsch, Stephanie Trentmann, Uwe Knippschild, Christian Rainer Wirtz, Timo Burster

Research output: Contribution to journal › Review article › peer-review

22 Citations (Scopus)

Abstract

One major obstacle in cancer therapy is chemoresistance leading to tumor recurrence and metastasis. Cancer stem cells, in particular glioblastoma stem cells, are highly resistant to chemotherapy, radiation, and immune recognition. In case of immune recognition, several survival mechanisms including, regulation of autophagy, proteases, and cell surface major histocompatibility complex class I molecules, are found in glioblastoma stem cells. In different pathways, cathepsins play a crucial role in processing functional proteins that are necessary for several processes and proper cell function. Consequently, strategies targeting these pathways in glioblastoma stem cells are promising approaches to interfere with tumor cell survival and will be discussed in this review.

Original language	English
Pages (from-to)	1010428317692227
Journal	Tumor Biology
Volume	39
Issue number	3
DOIs	https://doi.org/10.1177/1010428317692227
Publication status	Published - Mar 2017
Externally published	Yes

Keywords

Animals
Autophagy
Brain Neoplasms
Cathepsins
Glioblastoma
Humans
Neoplastic Stem Cells
Proteolysis
Journal Article
Review

Access to Document

10.1177/1010428317692227

Fingerprint Dive into the research topics of 'Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells'. Together they form a unique fingerprint.

Cite this

Cancer stem cells : The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells. / Bischof, Joachim; Westhoff, Mike-Andrew; Wagner, Johanna Elisabeth; Halatsch, Marc-Eric; Trentmann, Stephanie; Knippschild, Uwe; Wirtz, Christian Rainer; Burster, Timo.

In: Tumor Biology, Vol. 39, No. 3, 03.2017, p. 1010428317692227.

Research output: Contribution to journal › Review article › peer-review

@article{ffbd129a9dea4e19b9187febd14bef50,

title = "Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells",

abstract = "One major obstacle in cancer therapy is chemoresistance leading to tumor recurrence and metastasis. Cancer stem cells, in particular glioblastoma stem cells, are highly resistant to chemotherapy, radiation, and immune recognition. In case of immune recognition, several survival mechanisms including, regulation of autophagy, proteases, and cell surface major histocompatibility complex class I molecules, are found in glioblastoma stem cells. In different pathways, cathepsins play a crucial role in processing functional proteins that are necessary for several processes and proper cell function. Consequently, strategies targeting these pathways in glioblastoma stem cells are promising approaches to interfere with tumor cell survival and will be discussed in this review.",

keywords = "Animals, Autophagy, Brain Neoplasms, Cathepsins, Glioblastoma, Humans, Neoplastic Stem Cells, Proteolysis, Journal Article, Review",

author = "Joachim Bischof and Mike-Andrew Westhoff and Wagner, {Johanna Elisabeth} and Marc-Eric Halatsch and Stephanie Trentmann and Uwe Knippschild and Wirtz, {Christian Rainer} and Timo Burster",

year = "2017",

month = mar,

doi = "10.1177/1010428317692227",

language = "English",

volume = "39",

pages = "1010428317692227",

journal = "Oncodevelopmental Biology and Medicine",

issn = "1010-4283",

publisher = "Springer Netherlands",

number = "3",

}

TY - JOUR

T1 - Cancer stem cells

T2 - The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells

AU - Bischof, Joachim

AU - Westhoff, Mike-Andrew

AU - Wagner, Johanna Elisabeth

AU - Halatsch, Marc-Eric

AU - Trentmann, Stephanie

AU - Knippschild, Uwe

AU - Wirtz, Christian Rainer

AU - Burster, Timo

PY - 2017/3

Y1 - 2017/3

N2 - One major obstacle in cancer therapy is chemoresistance leading to tumor recurrence and metastasis. Cancer stem cells, in particular glioblastoma stem cells, are highly resistant to chemotherapy, radiation, and immune recognition. In case of immune recognition, several survival mechanisms including, regulation of autophagy, proteases, and cell surface major histocompatibility complex class I molecules, are found in glioblastoma stem cells. In different pathways, cathepsins play a crucial role in processing functional proteins that are necessary for several processes and proper cell function. Consequently, strategies targeting these pathways in glioblastoma stem cells are promising approaches to interfere with tumor cell survival and will be discussed in this review.

AB - One major obstacle in cancer therapy is chemoresistance leading to tumor recurrence and metastasis. Cancer stem cells, in particular glioblastoma stem cells, are highly resistant to chemotherapy, radiation, and immune recognition. In case of immune recognition, several survival mechanisms including, regulation of autophagy, proteases, and cell surface major histocompatibility complex class I molecules, are found in glioblastoma stem cells. In different pathways, cathepsins play a crucial role in processing functional proteins that are necessary for several processes and proper cell function. Consequently, strategies targeting these pathways in glioblastoma stem cells are promising approaches to interfere with tumor cell survival and will be discussed in this review.

KW - Animals

KW - Autophagy

KW - Brain Neoplasms

KW - Cathepsins

KW - Glioblastoma

KW - Humans

KW - Neoplastic Stem Cells

KW - Proteolysis

KW - Journal Article

KW - Review

U2 - 10.1177/1010428317692227

DO - 10.1177/1010428317692227

M3 - Review article

C2 - 28347245

VL - 39

SP - 1010428317692227

JO - Oncodevelopmental Biology and Medicine

JF - Oncodevelopmental Biology and Medicine

SN - 1010-4283

IS - 3

ER -